Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Stephen H Landy & Bob L Lobo. (2005) Migraine treatment throughout the lifecycle. Expert Review of Neurotherapeutics 5:3, pages 343-353.
Read now
Read now
Articles from other publishers (25)
Kyu‐Ho Yi, Ji‐Hyun Lee, Hye‐Won Hur, Hyung‐Jin Lee, You‐Jin Choi & Hee‐Jin Kim. (2023) Distribution of the intramuscular innervation of the triceps brachii: Clinical importance in the treatment of spasticity with botulinum neurotoxin. Clinical Anatomy.
Crossref
Crossref
Kyu‐Ho Yi, Kyu‐Lim Lee, Ji‐Hyun Lee, Hye‐Won Hu & Hee‐Jin Kim. (2022) Guidance to trigger point injection for treating myofascial pain syndrome: Intramuscular neural distribution of the quadratus lumborum. Clinical Anatomy 35:8, pages 1100-1106.
Crossref
Crossref
Kyu-Ho Yi, Ji-Hyun Lee & Hee-Jin Kim. (2022) Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome. Toxins 14:4, pages 271.
Crossref
Crossref
Kyu-Ho Yi, Ji-Hyun Lee, Dongkeun Kenneth Lee, Hye-Won Hu, Kyle K. Seo & Hee-Jin Kim. (2021) Anatomical locations of the motor endplates of sartorius muscle for botulinum toxin injections in treatment of muscle spasticity. Surgical and Radiologic Anatomy 43:12, pages 2025-2030.
Crossref
Crossref
Kyu‐Ho Yi, Kyu‐Lim Lee, Ji‐Hyun Lee, Hye‐Won Hu, Kangwoo Lee, Kyle K. Seo & Hee‐Jin Kim. (2020) Guidelines for botulinum neurotoxin injections in piriformis syndrome. Clinical Anatomy 34:7, pages 1028-1034.
Crossref
Crossref
Kyu‐Ho Yi, Hyung‐Jin Lee, You‐Jin Choi, Kangwoo Lee, Ji‐Hyun Lee & Hee‐Jin Kim. (2020) Anatomical guide for botulinum neurotoxin injection: Application to cosmetic shoulder contouring, pain syndromes, and cervical dystonia. Clinical Anatomy 34:6, pages 822-828.
Crossref
Crossref
Vicky Yu, Margit Juhász, Audris Chiang & Natasha Atanaskova Mesinkovska. (2018) Alopecia and Associated Toxic Agents: A Systematic Review. Skin Appendage Disorders 4:4, pages 245-260.
Crossref
Crossref
Yufeng Ye, Shiyu Liao, Baozhen Luo & Liyan Ni. (2016) Botulinum toxin treatment for essential palatal tremors presenting with nasal clicks instead of pulsatile tinnitus: a case report. Head & Face Medicine 12:1.
Crossref
Crossref
Michael B. Chancellor & Christopher P. SmithMichael B. Chancellor & Christopher P. Smith. 2011. Botulinum Toxin in Urology. Botulinum Toxin in Urology
155
168
.
Pankaj Modi. 2011. Nutrients, Dietary Supplements, and Nutriceuticals. Nutrients, Dietary Supplements, and Nutriceuticals
227
255
.
Sherif M. Hamdy, Hatem Samir, M. El-Sayed, Nermin Adel & Rasha Hasan. (2008) Botulinum toxin: could it be an effective treatment for chronic tension-type headache?. The Journal of Headache and Pain 10:1, pages 27-34.
Crossref
Crossref
Leonard A. Smith & Janice M. Rusnak. 2009. Botulinum Toxin. Botulinum Toxin
374
388.e1
.
Roberto Casale & Valeria Tugnoli. (2008) Botulinum Toxin for Pain. Drugs in R & D 9:1, pages 11-27.
Crossref
Crossref
Valeria Tugnoli, Jay Guido Capone, Roberto Eleopra, Rocco Quatrale, Mariachiara Sensi, Ernesto Gastaldo, Maria Rosaria Tola & Pierangelo Geppetti. (2007) Botulinum Toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin. Pain 130:1, pages 76-83.
Crossref
Crossref
David W. Dodick. 2009. Clinical Uses of Botulinum Toxins. Clinical Uses of Botulinum Toxins
229
242
.
Moshe Jakubowski, Peter J. McAllister, Zahid H. Bajwa, Thomas N. Ward, Patty Smith & Rami Burstein. (2006) Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A. Pain 125:3, pages 286-295.
Crossref
Crossref
Jack Gladstein. (2006) Pediatric headache. Current Treatment Options in Neurology 8:6, pages 451-456.
Crossref
Crossref
SD Silberstein, H Göbel, R Jensen, AH Elkind, R DeGryse, JMCM Walcott & C Turkel. (2016) Botulinum Toxin Type A in the Prophylactic Treatment of Chronic Tension-Type Headache: A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study. Cephalalgia 26:7, pages 790-800.
Crossref
Crossref
Joanne Borg-Stein. (2006) Treatment of Fibromyalgia, Myofascial Pain, and Related Disorders. Physical Medicine and Rehabilitation Clinics of North America 17:2, pages 491-510.
Crossref
Crossref
M Volcy, SJ Tepper, AM Rapoport, FD Sheftell & ME Bigal. (2016) Botulinum Toxin A for the Treatment of Greater Occipital Neuralgia and Trigeminal Neuralgia. Cephalalgia 26:3, pages 336-340.
Crossref
Crossref
Paola Sarchielli, Maria Luisa Mancini & Paolo Calabresi. (2006) Practical Considerations for the Treatment of Elderly Patients with Migraine. Drugs & Aging 23:6, pages 461-489.
Crossref
Crossref
B. Todd Troost. 2006. Current Therapy in Neurologic Disease. Current Therapy in Neurologic Disease
67
70
.
David W. Dodick, Alexander Mauskop, Arthur H. Elkind, Ronald DeGryse, Mitchell F. Brin & Stephen D. Silberstein. (2005) Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications: A Randomized Double‐Blind, Placebo‐Controlled Study. Headache: The Journal of Head and Face Pain 45:4, pages 315-324.
Crossref
Crossref
Ninan T. Mathew, Benjamin M. Frishberg, Marek Gawel, Rozalina Dimitrova, John Gibson & Catherine Turkel. (2005)
Botulinum Toxin Type A (BOTOX
®
) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double‐Blind, Placebo‐Controlled Trial
. Headache: The Journal of Head and Face Pain 45:4, pages 293-307.
Crossref
Crossref
Andrew Blumenfeld. (2004) Botulinum Toxin Type A for the Treatment of Headache: Pro. Headache: The Journal of Head and Face Pain 44:8, pages 825-830.
Crossref
Crossref